Privia Health Group, Inc. (NASDAQ:PRVA) Stock Position Lifted by JPMorgan Chase & Co.

JPMorgan Chase & Co. boosted its holdings in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 111.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 398,738 shares of the company's stock after acquiring an additional 210,354 shares during the period. JPMorgan Chase & Co. owned about 0.33% of Privia Health Group worth $7,795,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Park Avenue Securities LLC grew its position in Privia Health Group by 3.8% in the 4th quarter. Park Avenue Securities LLC now owns 14,697 shares of the company's stock worth $287,000 after purchasing an additional 532 shares during the last quarter. PNC Financial Services Group Inc. increased its position in Privia Health Group by 8.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company's stock valued at $140,000 after acquiring an additional 533 shares during the period. First Horizon Advisors Inc. raised its stake in Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock valued at $35,000 after acquiring an additional 632 shares in the last quarter. WINTON GROUP Ltd grew its stake in shares of Privia Health Group by 1.5% in the fourth quarter. WINTON GROUP Ltd now owns 60,607 shares of the company's stock worth $1,185,000 after purchasing an additional 902 shares in the last quarter. Finally, HighTower Advisors LLC grew its stake in shares of Privia Health Group by 5.0% in the fourth quarter. HighTower Advisors LLC now owns 19,469 shares of the company's stock worth $381,000 after purchasing an additional 932 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Privia Health Group Price Performance

Privia Health Group stock traded up $0.15 during midday trading on Tuesday, reaching $22.86. The stock had a trading volume of 646,530 shares, compared to its average volume of 780,537. Privia Health Group, Inc. has a twelve month low of $15.92 and a twelve month high of $26.04. The firm has a market cap of $2.77 billion, a price-to-earnings ratio of 228.62, a PEG ratio of 3.47 and a beta of 0.88. The firm's fifty day simple moving average is $23.75 and its two-hundred day simple moving average is $21.77.

Insider Activity

In other news, CFO David Mountcastle sold 5,630 shares of Privia Health Group stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total transaction of $125,999.40. Following the transaction, the chief financial officer now owns 179,676 shares in the company, valued at approximately $4,021,148.88. The trade was a 3.04 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 10.70% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the stock. Piper Sandler increased their target price on shares of Privia Health Group from $25.00 to $40.00 and gave the company an "overweight" rating in a research report on Friday, February 28th. Canaccord Genuity Group boosted their price objective on Privia Health Group from $29.00 to $30.00 and gave the stock a "buy" rating in a research note on Friday, February 28th. Barclays lifted their target price on Privia Health Group from $21.00 to $23.00 and gave the stock an "equal weight" rating in a report on Thursday, April 10th. Truist Financial upped their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the company a "buy" rating in a report on Thursday, April 10th. Finally, JMP Securities set a $29.00 price objective on shares of Privia Health Group in a research note on Friday, February 28th. One analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, Privia Health Group has an average rating of "Buy" and an average price target of $27.00.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.